Barrier Therapeutics Inc (BTRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

600 COLLEGE ROAD EAST PRINCETON, NJ 08540

Focuses on the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. The company's four most advanced product candidates are Sebazole, Zimycan, Hyphanox and Liarozole.

Are you looking for this stock instead?

View SEC Filings from BTRX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BTRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BTRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ERNSTER PETER

  • Director
No longer subject to file 2008-08-06 0

RAPHAEL CAROL

  • Director
No longer subject to file 2008-08-06 0

BENGAL ACQUISITION INC.

STIEFEL LABORATORIES, INC.

STIEFEL CHARLES W

  • 10% Owner
  • SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)
No longer subject to file 2008-08-06 0

CAMPBELL ROBERT E

  • Director
No longer subject to file 2008-08-05 0

REILLY DENNIS CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2008-08-05 0

SHROOT BRAHAM CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2008-08-05 0

BRISTOW ALBERT GENERAL COUNSEL & CORP SEC'Y

  • Officer
  • 10% Owner
No longer subject to file 2008-08-05 0

ALTOMARI ALFRED CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2008-08-05 0

CAUWENBERGH GEERT

  • Director
0 2008-08-05 0

ERICKSON EDWARD L

  • Director
No longer subject to file 2008-08-05 0

JACEY CHARLES F JR

  • Director
No longer subject to file 2008-08-05 0

EHMANN CARL

  • Director
No longer subject to file 2008-08-05 0

STIEFEL LABORATORIES, INC.

STIEFEL CHARLES W

  • 10% Owner
  • SEE FOOTNOTE (1)(2)SEE FOOTNOTE (1)(2)
34,266,494 2008-08-05 0

BENGAL ACQUISITION INC.

  • 10% Owner
34,266,494 2008-08-05 0

JP MORGAN PARTNERS BHCA LP

JPMP MASTER FUND MANAGER L P

JPMP CAPITAL CORP

JP MORGAN PARTNERS GLOBAL INVESTORS LP

J P MORGAN PARTNERS GLOBAL INVESTORS A LP

J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP

J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP

JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP

JPMP GLOBAL INVESTORS L P

  • 10% Owner
0 2008-08-05 0

AKKARAJU SRINIVAS

  • Director
0 2008-08-05 0

VANLENT ANNE EXEC VP & CFO

  • Officer
148,852 2008-03-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments